Boston Children’s Hospital and MIT labs are joining forces to develop novel RNA-based treatments for ALS. This collaboration aims to leverage the unique biological toolkits of each institution to accelerate therapeutic discovery for the neurodegenerative disease.
Opening Kapyn…